Abstract
We present the case of a patient with HIV and tuberculosis (TB) coinfection who initially developed paradoxical TB immune reconstitution inflammatory syndrome (TB-IRIS) post-antituberculous treatment and post-antiretroviral therapy initiation. Despite being managed effectively, lymphadenitis recurred as many as three times over the course of several years. Due to consistent culture-negative lymph node biopsies, the recurring lymphadenitis was eventually deemed inflammatory rather than microbiological recurrences. Cessation of anti-TB treatment led to symptom remission followed by a long asymptomatic period, corroborating the immunological nature of the episodes. However, 5 and 6 years after cessation of anti-TB treatment, respectively, lymphadenitis returned. In both instances, her symptoms regressed without treatment with anti-TB drugs. This case underscores the complexities of managing TB-IRIS and the necessity of differentiating between paradoxical TB-IRIS and other paradoxical reactions for appropriate treatment decisions. Recognition of such distinctions is crucial in guiding effective therapeutic interventions in TB-HIV coinfection scenarios.
Reference16 articles.
1. Global tuberculosis report 2023, licence: CC BY-NC-SA 3.0 IGO. Geneva World Health Organization; 2023.
2. HIV and Tuberculosis: a Deadly Human Syndemic
3. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis;Suthar;PLoS Med,2012
4. Tuberculosis-associated immune reconstitution inflammatory syndrome-an extempore game of misfiring with defense arsenals;Vignesh;Pathogens,2023
5. Detection of mycobacterium tuberculosis complex in Paraffin-embedded tissues by the new automated abbott realtime MTB assay;Fu;Ann Clin Lab Sci,2016